Cochrane Abstracts
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Janus Kinase Inhibitors for Maintenance of Remission in Ulcerative Colitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431022/all/Oral_Janus_kinase_inhibitors_for_maintenance_of_remission_in_ulcerative_colitis.
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431022/all/Oral_Janus_kinase_inhibitors_for_maintenance_of_remission_in_ulcerative_colitis. Accessed April 29, 2025.
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431022/all/Oral_Janus_kinase_inhibitors_for_maintenance_of_remission_in_ulcerative_colitis
Oral Janus Kinase Inhibitors for Maintenance of Remission in Ulcerative Colitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431022/all/Oral_Janus_kinase_inhibitors_for_maintenance_of_remission_in_ulcerative_colitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
ID - 431022
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431022/all/Oral_Janus_kinase_inhibitors_for_maintenance_of_remission_in_ulcerative_colitis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
